MENU
+Compare
NPCE
Stock ticker: NASDAQ
AS OF
Apr 24 closing price
Price
$11.25
Change
+$0.34 (+3.12%)
Capitalization
385.2M

NPCE Neuropace Forecast, Technical & Fundamental Analysis

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures... Show more

NPCE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for NPCE with price predictions
Apr 23, 2025

Momentum Indicator for NPCE turns negative, indicating new downward trend

NPCE saw its Momentum Indicator move below the 0 level on April 08, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned negative. In of the 84 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for NPCE turned negative on April 08, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at .

NPCE moved below its 50-day moving average on April 04, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NPCE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 45 cases where NPCE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NPCE advanced for three days, in of 213 cases, the price rose further within the following month. The odds of a continued upward trend are .

NPCE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 151 cases where NPCE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NPCE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (18.657) is normal, around the industry mean (23.728). P/E Ratio (0.000) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (5.371) is also within normal values, averaging (41.794).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NPCE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
NPCE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NPCE is expected to report earnings to rise 34.33% to -24 cents per share on May 13

Neuropace NPCE Stock Earnings Reports
Q1'25
Est.
$-0.24
Q4'24
Beat
by $0.07
Q3'24
Beat
by $0.08
Q2'24
Beat
by $0.04
Q1'24
Est.
$-0.32
The last earnings report on March 04 showed earnings per share of -18 cents, beating the estimate of -25 cents. With 101.82K shares outstanding, the current market capitalization sits at 385.20M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
455 N. Bernardo Avenue
Phone
+1 650 237-2700
Employees
167
Web
https://www.neuropace.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BERCX15.57N/A
N/A
Carillon Chartwell Mid Cap Value I
FSPHX25.32N/A
N/A
Fidelity Select Health Care
HADAX28.29N/A
N/A
Hartford Balanced HLS IA
AWTAX19.45N/A
N/A
Virtus Duff & Phelps Water A
NWGPX24.50N/A
N/A
Nationwide WCM Focused Sm Cp A

NPCE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NPCE has been loosely correlated with FNA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if NPCE jumps, then FNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NPCE
1D Price
Change %
NPCE100%
-0.27%
FNA - NPCE
44%
Loosely correlated
N/A
STVN - NPCE
37%
Loosely correlated
+0.93%
IRMD - NPCE
33%
Poorly correlated
+1.23%
NTRA - NPCE
32%
Poorly correlated
+2.72%
HBIO - NPCE
32%
Poorly correlated
+0.97%
More